Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.19−0.02 (-10.00%)
Close on Nov 18, 2026Market cap $852.76KP/E –Yield –
Oragenics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Oragenics's gross profit for the twelve months ending Dec 31, 2016 was $0. For fiscal 2017 it was $0. The highest annual figure on record is $730.82K in fiscal 2011.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $0 | – |
| FY2016 | Dec 31, 2016 | $0 | – |
| FY2015 | Dec 31, 2015 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $570.33K | -17.2% |
| FY2013 | Dec 31, 2013 | $688.88K | +52.0% |
| FY2012 | Dec 31, 2012 | $453.30K | -38.0% |
| FY2011 | Dec 31, 2011 | $730.82K | +84.0% |
| FY2010 | Dec 31, 2010 | $397.12K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?